Neuraminidase (NA)

Neuraminidase (NA)

Neuraminidase (NA) 詳細

Molecule Name
Neuraminidase
分子の別称
NA,Neuraminidase
Drug Development Progress
治験薬の数5
市販薬剤の数4
研究&開発段階Approved
ターゲットの別称
Neuraminidase
バックグランド
Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Neuraminidase (NA) 製品リスト

Species
  • Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023)(1)
  • Influenza A virus (A/Victoria/4897/2022)(1)
  • Influenza A virus (Missouri/11/2025)(1)
  • Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024)(1)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(1)
Host
  • HEK293(4)
Conjugate
  • Unconjugated(3)
  • Biotin-labeled(1)
Grade
  • RUO(4)
Low Endotoxin
  • No(4)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
Neuraminidase (NA)
Influenza A virus (Missouri/11/2025) NA (H1N1) Protein, His Tag
Influenza A virus (Missouri/11/2025)
HEK293
SDS-PAGE
ELISASPR

$350.00

100ug
Neuraminidase (NA)
Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024) NA (H3N2) Protein, His Tag
Influenza A virus (Sydney/1359/2024)& (Singapore/GP20238/2024)
HEK293
SDS-PAGE
SPR

$350.00

100ug
Neuraminidase (NA)
Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023) NA(H3N2) Protein, His Tag
Influenza A virus (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023)
HEK293
SDS-PAGE

$360.00

100ug
Neuraminidase (NA)
Avitag
NEE-V82Q3
Biotinylated Influenza A virus (A/Victoria/4897/2022) NA (H1N1) Protein, Avitag™,His Tag
Influenza A virus (A/Victoria/4897/2022)
HEK293
SDS-PAGE

$380.00

25ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

FAQ

What should be verified before selecting NA?

Confirm subtype, strain, tag or biotinylation, host, and the assay readout required.

Can any recombinant NA protein be used in an enzyme-activity assay?

Check the selected construct’s activity data and assay suitability. Binding validation alone does not establish neuraminidase enzymatic activity.

Which NA formats suit capture assays?

Consider the biotinylated His/AviTag construct for streptavidin capture; verify binding performance for the assay.

Can NA reagents support antibody studies?

The portfolio includes an anti-NA antibody and serology-related kit, in addition to recombinant NA proteins.

Why match the NA strain to the study?

The listed proteins are strain-defined; sequence and subtype differences can affect binding and assay recognition.

What non-protein NA reagents are available?

The portfolio also includes an anti-NA antibody and a mouse anti-influenza antibody titer kit.

Are biotinylated NA proteins available?

Yes. Options include biotinylated H1N1 NA with His and AviTag.

Which NA protein subtypes are available?

Available options include influenza A H1N1 and H3N2 neuraminidase proteins from named strains.
Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CD388CD-388; JNJ-0953; CD388Phase 3 ClinicalCidara Therapeutics Inc
Influenza, Human
詳細
Peramivir Inhalation Solution (Langtian Medical Tech)Phase 2 ClinicalLangtian Medical Technology (Wuhan) Co Ltd
Influenza A virus infections; Influenza B virus infection
詳細
Peramivir Inhalation Solution (广州南鑫药业)Phase 2 ClinicalGuangzhou Nanxin Pharma Co Ltd
Arthralgia; Cough; Fatigue; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Musculoskeletal Pain; Nasal Obstruction
詳細
Oseltamivir/PimodivirPhase 1 ClinicalJohnson & Johnson
Influenza A virus infections
詳細
Oseltamivir orally disintegrating tablets(Hefei Industrial Pharma)HY-100209Phase 1 ClinicalHefei Industrial Pharmaceutical Co Ltd
Influenza A virus infections; Influenza B virus infection
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Laninamivir Octanoate HydrateCS-8958; R-118958ApprovedDaiichi Sankyo Co LtdInavirJapanInfluenza B virus infection; Influenza A virus infections; Influenza, Humannull2010-09-10
Asthma; Influenza A virus infections; Influenza B virus infection; Influenza, Human
詳細
ZanamivirGG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2enApprovedGlaxosmithkline Plc依乐韦, RelenzaUnited StatesInfluenza, HumanGlaxosmithkline Plc1999-07-26
Arthralgia; Dengue; Diabetes Mellitus, Type 2; Influenza, Human; Orthomyxoviridae Infections
詳細
Oseltamivir PhosphateRo-64-0796; RO-640796; GS-4104; EN-241104; RO-640796/002; GS-4104/002; GS-4104-002ApprovedF. Hoffmann-La Roche Ltd, Gilead Sciences IncTamiflu, Hanmi Flu, 达菲SwitzerlandInfluenza, HumanF. Hoffmann-La Roche Ltd1999-09-21
Influenza A virus infections; Influenza in Birds; Influenza, Human; Kidney Failure, Chronic; Obesity; Purpura, Thrombocytopenic, Idiopathic
詳細
Peramivir HydrateBCX-1812; JNJ-2; S-021812; RWJ-270201ApprovedBiocryst Pharmaceuticals IncPeramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu PremixJapanInfluenza, Humannull2010-01-13
Cough; Fatigue; Fever; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Myalgia; Nasal Obstruction; Pharyngitis
詳細
Customer Reviews